APA (7th ed.) Citation

Chen, H., & Song, J. (2024). Efficacy and safety analysis of donafenib combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A prospective, single-arm, single center, phase II clinical study. Journal of clinical oncology, 42(16_suppl), e16134. https://doi.org/10.1200/JCO.2024.42.16_suppl.e16134

Chicago Style (17th ed.) Citation

Chen, Hua, and Jinlong Song. "Efficacy and Safety Analysis of Donafenib Combined with Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Prospective, Single-arm, Single Center, Phase II Clinical Study." Journal of Clinical Oncology 42, no. 16_suppl (2024): e16134. https://doi.org/10.1200/JCO.2024.42.16_suppl.e16134.

MLA (9th ed.) Citation

Chen, Hua, and Jinlong Song. "Efficacy and Safety Analysis of Donafenib Combined with Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Prospective, Single-arm, Single Center, Phase II Clinical Study." Journal of Clinical Oncology, vol. 42, no. 16_suppl, 2024, p. e16134, https://doi.org/10.1200/JCO.2024.42.16_suppl.e16134.